Early therapy evaluation of intra-arterial trastuzumab injection in a human breast cancer xenograft model using multiparametric MR imaging
CONCLUSION: IA treatment with trastuzumab potentially affects the early response to treatment, including decreased tumor growth and decrease of Ktrans, in a preclinical brain tumor model.PMID:38701062 | DOI:10.1371/journal.pone.0300171
Source: Cancer Control - Category: Cancer & Oncology Authors: Bo Kyu Kim Byungjun Kim Sung-Hye You Moon-Sun Jang Geun Ho Im Keon-Ha Kim Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Breast Cancer | Cancer | Cancer & Oncology | Herceptin | MRI Scan | Neurology